SEC Form 4 · accession 0001140361-16-048297
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jan 19, 2016
Accepted (ET)
Jan 21, 2016 · 10:08 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Jan 19, 2016 | P | 4,300 | $0.7897 | A | 6,428,674 | I | By Trust |
| Common StockF3,F1 | Jan 20, 2016 | P | 19,900 | $0.7367 | A | 6,448,574 | I | By Trust |
| Common Stock | holding | — | — | — | 14,800 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.
- F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7801 to $0.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7101 to $0.765, inclusive.